Generated by Llama 3.3-70B| Sandra Horning | |
|---|---|
| Name | Sandra Horning |
| Occupation | Physician and researcher |
Sandra Horning is a renowned American physician and researcher, known for her work in the field of Hematology and Oncology. She has made significant contributions to the understanding and treatment of Lymphoma and other Cancer types, collaborating with institutions such as the Stanford University School of Medicine and the National Cancer Institute. Her research has been influenced by the work of prominent scientists like James Allison and Tasuku Honjo, who were awarded the Nobel Prize in Physiology or Medicine for their discovery of Cancer Immunotherapy. Horning's work has also been shaped by her involvement with organizations like the American Society of Clinical Oncology and the American Association for Cancer Research.
Sandra Horning was born and raised in the United States, where she developed an interest in Medicine and Science from an early age. She pursued her undergraduate degree at Yale University, followed by her medical degree at the University of Iowa College of Medicine. During her time at Iowa, she was exposed to the work of notable researchers like Harold Varmus and Michael Bishop, who were awarded the Nobel Prize in Physiology or Medicine for their discoveries on the Oncogene theory. Horning's education was also influenced by her involvement with the National Institutes of Health and the Howard Hughes Medical Institute.
Horning began her career as a physician and researcher at the Stanford University School of Medicine, where she worked alongside prominent scientists like Irving Weissman and Stuart Schreiber. Her work at Stanford focused on the development of new treatments for Lymphoma and other Cancer types, including Diffuse Large B-Cell Lymphoma and Follicular Lymphoma. She has also collaborated with researchers at the University of California, San Francisco and the Dana-Farber Cancer Institute, and has been involved with organizations like the Lymphoma Research Foundation and the Cancer Research Institute. Horning's career has been shaped by her involvement with the Food and Drug Administration and the National Comprehensive Cancer Network.
Horning's research has made significant contributions to the understanding and treatment of Lymphoma and other Cancer types. She has published numerous papers in prestigious journals like the New England Journal of Medicine and the Journal of Clinical Oncology, and has presented her work at conferences like the American Society of Hematology and the European Hematology Association. Her work has been influenced by the research of scientists like Brian Druker and Charles Sawyers, who developed the Tyrosine Kinase Inhibitor Imatinib for the treatment of Chronic Myeloid Leukemia. Horning has also collaborated with researchers at the Memorial Sloan Kettering Cancer Center and the University of Texas MD Anderson Cancer Center, and has been involved with organizations like the Leukemia & Lymphoma Society and the Cancer Support Community.
Horning has received numerous awards and honors for her contributions to the field of Oncology and Hematology. She has been recognized by organizations like the American Cancer Society and the American Society of Clinical Oncology, and has received awards like the ASCO Lifetime Achievement Award and the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship. Her work has also been acknowledged by the National Cancer Institute and the National Institutes of Health, and she has been elected as a member of the Institute of Medicine and the American Association for the Advancement of Science. Horning's awards and honors are a testament to her dedication to the field of Cancer Research and her commitment to improving the lives of patients with Lymphoma and other Cancer types. Category:American physicians